Genomadix Bioscience announces strategic investment from Canon U.S.A.


Genomadix Bioscience today announced that it has received a strategic investment from Canon U.S.A., Inc., a leader in digital imaging solutions. As part of the investment, Seymour Liebman will be joining Genomadix’s Board of Directors.

Mr. Liebman is executive vice president, chief administrative officer and general counsel of Canon U.S.A., Inc., senior executive officer of Canon Inc., vice chairman of Canon Solutions America, Inc. and is a member of the Board of Directors of Canon BioMedical, Inc., a recently established wholly-owned subsidiary of Canon U.S.A., Inc.

In addition to the strategic investment, Canon BioMedical and Genomadix Bioscience plan to explore areas to work together on the development of future diagnostic products.


Discover More Articles

Which Test Are You Looking For?